Stem cell delivery vehicle has potential for future AMD sufferers

Article

Scientists at the University of Southampton have developed biodegradable polymer microspheres which may have the ability to deliver stem cells to damaged retina photoreceptor cells to help with their repair.

Scientists at the University of Southampton have developed biodegradable polymer microspheres which may have the ability to deliver stem cells to damaged retina photoreceptor cells to help with their repair, which offers huge promise for future AMD sufferers.

Andrew Lotery, an eye surgeon and founder of the charity Gift of Sight is working with the researchers to bring the development into clinical applications. According to a report in Chemistry World:, August 2010, the team will be establishing a method to ensure a suspension of microspheres decorated with stem cells, which will be arranged in a particular orientation on the surface could be injected under the retina at the location of the damage. The microspheres would then deliver the stems cells to the damaged photoreceptors and start to repair cells prior to the microspheres biodegrading.

David Chau, told Chemistry World: “Future challenges would include the possibility of incorporating growth factors, drugs or antibiotics into the microspheres that degrade over time to aid repair and regeneration or prevent inflammation following surgery.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.